The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes

Jon G. Mabley, Pal Pacher, Kanneganti G.K. Murthy, William Williams, Garry J. Southan, Andrew L. Salzman, Csaba Szabo

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences